Prevalence of Extended Spectrum β-Lactamase and Antimicrobial Susceptibility Pattern of Clinical Isolates of Pseudomonas from Patients of Khyber Pakhtunkhwa, Pakistan

Table 1

Cumulative susceptibility pattern of Pseudomonas spp. to various antimicrobial agents.

Antimicrobial agent	Codes	Sensitive; (%)	Intermediate; (%)	Resistant; (%)
Amoxicillin	AML	50 (14.97)	39 (11.68)	245 (73.35)
Amoxicillin + clavulanic acid	AMC	82 (24.55)	26 (7.78)	226 (67.66)
Piperacillin + tazobactam	TZP	203 (60.78)	55 (16.47)	76 (22.75)
Cefoperazone + sulbactam	SCF	231 (69.16)	44 (13.17)	59 (17.66)
Cefaclor	CEC	71 (21.26)	22 (6.59)	241 (72.16)
Ceftazidime	CAZ	111 (33.23)	27 (8.08)	196 (58.68)
Ceftriaxone	CRO	121 (36.23)	37 (11.08)	176 (52.69)
Cefepime	FEP	162 (48.50)	17 (5.09)	155 (46.41)
Sparfloxacin	SPX	186 (55.69)	14 (4.19)	134 (40.12)
Ciprofloxacin	CIP	168 (50.30)	19 (5.69)	147 (44.01)
Gatifloxacin	GTX	149 (44.61)	84 (25.15)	101 (30.24)
Enoxacin	ENX	117 (35.03)	37 (11.08)	180 (53.89)
Moxifloxacin	MXF	206 (61.68)	35 (10.48)	93 (27.84)
Erythromycin	E	64 (19.16)	22 (6.59)	248 (74.25)
Clarithromycin	CLR	142 (42.51)	37 (11.08)	155 (46.41)
Meropenem	MEM	304 (91.02)	4 (1.20)	26 (7.78)
Imipenem	IPM	282 (84.43)	15 (4.49)	37 (11.08)
Gentamycin	CN	62 (18.56)	24 (7.19)	248 (74.25)
Amikacin	AK	216 (64.67)	17 (5.09)	101 (30.24)
Doxycycline	DO	34 (10.18)	19 (5.69)	281 (84.13)